Tuesday, March 29, 2022 10:28:54 AM
You know....many people said that this company is not for real. They said that no progress is being made. They said we would never get on the Nasdaq exchange. Lies were told about the relationship between Sunshine and the Universities with whom Sunshine is working.
Fast forward to now-
1. The company has funding for the next two years of research.
2. We are trading on an exchange that provides FAR greater liquidity and access to institutional investors.
3. The company is now around 40 to 50 percent owned by funds and accredited investors.
4. The company has a very competent PR/IR firm working to attract new investors.
5. The company is currently applying or has applied for fast track and approval for human trials.
We are in a MUCH better position than we were a year ago. We are light years ahead.
So yeah, talk to me again in May. I like our chances here quite a bit.
Fast forward to now-
1. The company has funding for the next two years of research.
2. We are trading on an exchange that provides FAR greater liquidity and access to institutional investors.
3. The company is now around 40 to 50 percent owned by funds and accredited investors.
4. The company has a very competent PR/IR firm working to attract new investors.
5. The company is currently applying or has applied for fast track and approval for human trials.
We are in a MUCH better position than we were a year ago. We are light years ahead.
So yeah, talk to me again in May. I like our chances here quite a bit.
Recent SBFM News
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
